NCT03025828View on ClinicalTrials.gov

Adrenocorticotropic Hormone in Membranous Nephropathy

PHASE4CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 19, 2018

Primary Completion Date

December 16, 2020

Study Completion Date

December 16, 2020

Conditions
Membranous Nephropathy
Interventions
DRUG

ACTHar

for 6 months

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT03025828 - Adrenocorticotropic Hormone in Membranous Nephropathy | Biotech Hunter | Biotech Hunter